Stay updated on Immunotherapy for Anal Canal Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.

Latest updates to the Immunotherapy for Anal Canal Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.6.5 was added to the page, signaling a new revision update. A large set of study documents and glossary terms was removed from the page, changing the available resources and terminology displayed.SummaryDifference21%

- Check13 days agoChange DetectedUPMC Hillman Cancer Center is now listed as a participating site, replacing the University of Pittsburgh Cancer Institute (UPCI). This update reflects a change in the trial's affiliated institutions and current participation.SummaryDifference0.1%

- Check20 days agoChange DetectedTwo additions show dates 2018-07-13 and 2018-08-07 along with Revision: v3.6.4, while three deletions remove 2026-04-01, 2026-04-22, and Revision: v3.6.3; these entries document administrative version updates to the page rather than changes to the study itself.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3. This is an incremental update to the page’s software revision and does not modify the study text or data.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2. This indicates a small update to the page's documentation/versioning without changing study information.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study's site roster was updated to add UT MD Anderson Cancer Center and remove M D Anderson Cancer Center, reflecting changes in participating institutions (dates 2026-06-16/17 and 2026-05-12/28).SummaryDifference0.1%

Stay in the know with updates to Immunotherapy for Anal Canal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.